// App-Quantinova.ai

TCT-159 : Percutaneous Coronary Intervention of Large Coronary Vessels With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 4.5/5.0 mm Stent: Primary Outcomes of the EVOLVE Large Vessel Study

Researchers

Presenter

  • Robert Stoler

Principal Investigators

  • Frances Wood

  • Zafir Hawa

  • Steven Rudick

  • Punag Divanji

  • Robert Yeh

  • Bernardo Stein

  • Wayne Batchelor

  • Elissa Altin

  • Paul Underwood

  • Dominic Allocco

Medical Centers

  • North Kansas City Hospital, Shawnee Mission, Arkansas, USA

  • Inova Heart and Vascular Institute, Falls Church, Virginia, USA

  • Boston Scientific, Phoenix, Arizona, USA

  • Baylor Scott & White Heart and Vascular Hospital, Dallas, Texas, USA

  • The Lindner Center for Research and Education at the Christ Hospital, Cincinnati, Ohio, USA

  • WakeMed Health & Hospitals, Raleigh, North Carolina, USA

  • Oregon Health and Science University, Portland, Oregon, USA

  • Morton Plant Mease Healthcare System, Clearwater, Florida, USA

  • Yale University, Fairfield, Connecticut, USA

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

  • Boston Scientific, Maple Grove, Minnesota, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved